|
AU2004211584B2
(en)
*
|
2003-01-31 |
2009-11-12 |
Promega Corporation |
Covalent tethering of functional groups to proteins
|
|
BRPI0614805A2
(pt)
|
2005-08-10 |
2011-04-12 |
Univ Johns Hopkins |
poliaminas úteis como produtos terapêuticos antiparasìticos e anticáncer e como inibidores de demetilase lisina-especìficos
|
|
WO2008054827A2
(en)
*
|
2006-11-03 |
2008-05-08 |
Pharmacyclics, Inc. |
Bruton's tyrosine kinase activity probe and method of using
|
|
WO2008127734A2
(en)
|
2007-04-13 |
2008-10-23 |
The Johns Hopkins University |
Lysine-specific demethylase inhibitors
|
|
EP2361242B1
(en)
|
2008-10-17 |
2018-08-01 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
WO2010084160A1
(en)
|
2009-01-21 |
2010-07-29 |
Oryzon Genomics S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
US8389580B2
(en)
|
2009-06-02 |
2013-03-05 |
Duke University |
Arylcyclopropylamines and methods of use
|
|
WO2010143582A1
(ja)
|
2009-06-11 |
2010-12-16 |
公立大学法人名古屋市立大学 |
フェニルシクロプロピルアミン誘導体及びlsd1阻害剤
|
|
WO2011022489A2
(en)
|
2009-08-18 |
2011-02-24 |
The Johns Hopkins University |
(bis) urea and (bis) thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders
|
|
CA2812683C
(en)
*
|
2009-09-25 |
2017-10-10 |
Oryzon Genomics S.A. |
Lysine specific demethylase-1 inhibitors and their use
|
|
US8946296B2
(en)
|
2009-10-09 |
2015-02-03 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
|
|
HUE030938T2
(en)
|
2010-04-19 |
2017-06-28 |
Oryzon Genomics Sa |
Lysine-specific demethylase-1 inhibitors and their use
|
|
JP5934184B2
(ja)
|
2010-04-20 |
2016-06-15 |
ウニヴェルシタ・デグリ・ストゥディ・ディ・ローマ・ラ・サピエンツァ |
ヒストンデメチラーゼｌｓｄ１及び／又はｌｓｄ２の阻害剤としてのトラニルシプロミン誘導体
|
|
MX341732B
(es)
|
2010-07-29 |
2016-08-30 |
Oryzon Genomics S A * |
Inhibidores de la demetilasa lsd1 basados en arilciclopropilamina y sus usos médicos.
|
|
WO2012013727A1
(en)
|
2010-07-29 |
2012-02-02 |
Oryzon Genomics S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
US9527805B2
(en)
|
2010-09-10 |
2016-12-27 |
Robert A. Casero |
Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
|
|
US9061966B2
(en)
|
2010-10-08 |
2015-06-23 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
WO2012071469A2
(en)
|
2010-11-23 |
2012-05-31 |
Nevada Cancer Institute |
Histone demethylase inhibitors and uses thereof for treatment o f cancer
|
|
SG193241A1
(en)
*
|
2011-03-25 |
2013-10-30 |
Glaxosmithkline Ip No 2 Ltd |
Cyclopropylamines as lsd1 inhibitors
|
|
CN103842332B
(zh)
|
2011-08-09 |
2016-08-17 |
武田药品工业株式会社 |
环丙胺化合物
|
|
JP6122006B2
(ja)
|
2011-08-15 |
2017-04-26 |
ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション |
ヒストン脱メチル化酵素阻害剤としての、置換された（ｅ）−ｎ’−（１−フェニルエチリデン）ベンゾヒドラジド類似体
|
|
WO2013033688A1
(en)
|
2011-09-01 |
2013-03-07 |
The Brigham And Women's Hospital, Inc. |
Treatment of cancer
|
|
WO2013057322A1
(en)
|
2011-10-20 |
2013-04-25 |
Oryzon Genomics, S.A. |
(hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
|
|
BR112014009306B1
(pt)
*
|
2011-10-20 |
2021-07-20 |
Oryzon Genomics S.A. |
Compostos de (hetero)aril ciclopropilamina como inibidores de lsd1
|
|
WO2014058071A1
(ja)
|
2012-10-12 |
2014-04-17 |
武田薬品工業株式会社 |
シクロプロパンアミン化合物およびその用途
|
|
JP6238908B2
(ja)
|
2012-11-28 |
2017-11-29 |
京都府公立大学法人 |
リシン構造を有するｌｓｄ１選択的阻害薬
|
|
US9144555B2
(en)
|
2012-11-30 |
2015-09-29 |
Darlene E. McCord |
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
|
|
EP2740474A1
(en)
|
2012-12-05 |
2014-06-11 |
Instituto Europeo di Oncologia S.r.l. |
Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
|
|
CN103054869A
(zh)
|
2013-01-18 |
2013-04-24 |
郑州大学 |
含三唑基的氨基二硫代甲酸酯化合物在制备以lsd1为靶标药物中的应用
|
|
WO2014164867A1
(en)
|
2013-03-11 |
2014-10-09 |
Imago Biosciences |
Kdm1a inhibitors for the treatment of disease
|
|
WO2014151282A1
(en)
*
|
2013-03-15 |
2014-09-25 |
Promega Corporation |
Substrates for covalent tethering of proteins to functional groups or solid surfaces
|
|
JP6525162B2
(ja)
|
2013-06-19 |
2019-06-05 |
ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション |
ヒストン脱メチル化酵素阻害剤としての置換（ｅ）−ｎ’−（１−フェニルエチリデン）ベンゾヒドラジド類似体
|
|
CN103319466B
(zh)
|
2013-07-04 |
2016-03-16 |
郑州大学 |
含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用
|
|
MX383590B
(es)
|
2013-08-06 |
2025-03-11 |
Imago Biosciences Inc |
Inhibidores de kdm1a para el tratamiento de enfermedades.
|
|
US9186391B2
(en)
|
2013-08-29 |
2015-11-17 |
Musc Foundation For Research Development |
Cyclic peptide inhibitors of lysine-specific demethylase 1
|
|
WO2015031564A2
(en)
|
2013-08-30 |
2015-03-05 |
University Of Utah |
Substituted-1h-benzo[d]imidazole series compounds as lysine-specfic demethylase 1 (lsd1) inhibitors
|
|
SI3080100T1
(sl)
|
2013-12-11 |
2023-04-28 |
Celgene Quanticel Research, Inc. |
Inhibitorji lizin specifične demetilaze-1
|
|
EP3102034A4
(en)
|
2014-02-07 |
2017-07-12 |
MUSC Foundation For Research Development |
Aminotriazole- and aminotetrazole-based kdm1a inhibitors as epigenetic modulators
|
|
TWI720451B
(zh)
|
2014-02-13 |
2021-03-01 |
美商英塞特控股公司 |
作為lsd1抑制劑之環丙胺
|
|
US9493442B2
(en)
|
2014-02-13 |
2016-11-15 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
KR102421235B1
(ko)
|
2014-02-13 |
2022-07-15 |
인사이트 코포레이션 |
Lsd1 저해제로서 사이클로프로필아민
|
|
EP3114109A4
(en)
|
2014-03-07 |
2017-10-18 |
The Johns Hopkins University |
Inhibitors of histone lysine specific demethylase (lsd1) and histone deacetylases (hdacs)
|
|
CN103893163B
(zh)
|
2014-03-28 |
2016-02-03 |
中国药科大学 |
2-([1，1′-联苯]-4-基)2-氧代乙基4-((3-氯-4-甲基苯基)氨基)-4-氧代丁酸酯在制备lsd1抑制剂药物中的应用
|
|
CN106459024B
(zh)
|
2014-04-11 |
2019-11-05 |
武田药品工业株式会社 |
环丙胺化合物及其用途
|
|
CN103961340B
(zh)
|
2014-04-30 |
2019-06-25 |
南通中国科学院海洋研究所海洋科学与技术研究发展中心 |
一类lsd1抑制剂及其应用
|
|
WO2015168466A1
(en)
|
2014-05-01 |
2015-11-05 |
Quanticel Pharmaceuticals, Inc. |
Inhibitors of lysine specific demethylase-1
|
|
JP6320570B2
(ja)
|
2014-05-30 |
2018-05-09 |
イエオ−イスティトゥート・エウロペオ・ディ・オンコロジア・エッセ・エッレ・エッレ |
ヒストンデメチラーゼ阻害剤としてのシクロプロピルアミン化合物
|
|
CN104119280B
(zh)
|
2014-06-27 |
2016-03-16 |
郑州大学 |
含氨基类脲与端炔结构单元的嘧啶衍生物、制备方法及应用
|
|
RS60658B1
(sr)
|
2014-06-27 |
2020-09-30 |
Celgene Quanticel Research Inc |
Inhibitori lizin specifične demetilaze-1
|
|
SG11201610975RA
(en)
|
2014-07-03 |
2017-01-27 |
Celgene Quanticel Res Inc |
Inhibitors of lysine specific demethylase-1
|
|
MX391865B
(es)
|
2014-07-03 |
2025-03-21 |
Celgene Quanticel Res Inc |
Inhibidores de demetilasa-1 especifica de lisina.
|
|
TWI687419B
(zh)
|
2014-07-10 |
2020-03-11 |
美商英塞特公司 |
作為ｌｓｄ１抑制劑之咪唑并吡啶及咪唑并吡嗪
|
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
|
TW201613925A
(en)
|
2014-07-10 |
2016-04-16 |
Incyte Corp |
Imidazopyrazines as LSD1 inhibitors
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
JP6692350B2
(ja)
|
2014-09-05 |
2020-05-13 |
セルジーン クオンティセル リサーチ，インク． |
リジン特異的なデメチラーゼ−１の阻害剤
|
|
EP2993175A1
(en)
|
2014-09-05 |
2016-03-09 |
IEO - Istituto Europeo di Oncologia Srl |
Thienopyrroles as histone demethylase inhibitors
|
|
JP6636031B2
(ja)
|
2015-01-30 |
2020-01-29 |
ジェネンテック， インコーポレイテッド |
治療用化合物およびその使用
|
|
RS66458B1
(sr)
|
2015-02-12 |
2025-02-28 |
Imago Biosciences Inc |
Kdm1a inhibitor i njegova primena u terapiji
|
|
SG11201708047UA
(en)
|
2015-04-03 |
2017-10-30 |
Incyte Corp |
Heterocyclic compounds as lsd1 inhibitors
|
|
CN106045862B
(zh)
|
2015-04-10 |
2019-04-23 |
上海迪诺医药科技有限公司 |
环丙胺类螺(杂)环化合物、其药物组合物及应用
|
|
US10526287B2
(en)
|
2015-04-23 |
2020-01-07 |
Constellation Pharmaceuticals, Inc. |
LSD1 inhibitors and uses thereof
|
|
EP3090998A1
(en)
|
2015-05-06 |
2016-11-09 |
F. Hoffmann-La Roche AG |
Solid forms
|
|
WO2017004519A1
(en)
|
2015-07-02 |
2017-01-05 |
University Of Utah Research Foundation |
Substituted benzohydrazide analogs as histone demethylase inhibitors
|
|
CN110402244B
(zh)
|
2015-08-12 |
2023-02-03 |
因赛特公司 |
Lsd1抑制剂的盐
|
|
ES3042059T3
(en)
*
|
2016-03-16 |
2025-11-18 |
Oryzon Genomics Sa |
Methods to determine kdm1a target engagement and chemoprobes useful therefor
|